Skip to Main Content

In his speech on Monday on ways to combat high drug costs, Health and Human Services Secretary Alex Azar was careful not to mention any one company by name when talking about some medicines that Medicare Part D must automatically cover.

But it certainly appears that he was pointing a finger at Celgene.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED